FOLFIRINOX induction therapy for stage III pancreatic adenocarcinoma

BACKGROUND: FOLFIRINOX therapy for pancreatic ductal adenocarcinoma (PDAC) has been reported to result in objective response rates that are 2–3 fold higher than other regimens. Our goal was to assess response rates and resection rates in locally unresectable (stage III) patients initially treated wi...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Ann Surg Oncol
Main Authors: Sadot, Eran, Doussot, Alexandre, O’Reilly, Eileen M., Lowery, Maeve A., Goodman, Karyn A., Do, Richard Kinh Gian, Tang, Laura H., Gönen, Mithat, D’Angelica, Michael I., DeMatteo, Ronald P., Kingham, T. Peter, Jarnagin, William R., Allen, Peter J.
Format: Artigo
Sprog:Inglês
Udgivet: 2015
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4849545/
https://ncbi.nlm.nih.gov/pubmed/26065868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-015-4647-4
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker